ADHD in the News 2024-05-23
ADHD diagnoses are rising. 1 in 9 U.S. kids have gotten one, new study finds
About 1 in 9 children in the U.S., between the ages of 3 and 17, have been diagnosed with ADHD. That's according to a new report from the Centers for Disease Control and Prevention that calls attention-deficit/hyperactivity disorder an "expanding public health concern."
Doctors Are Still Figuring Out Adult A.D.H.D.
It’s one of the most common psychiatric disorders in adults. Yet there are no U.S. guidelines for diagnosing and treating patients beyond childhood.
ADHD drug shortage shows signs of letting up, but some patients still struggle
Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are still struggling to get prescriptions filled.
Teva’s Adderall makes it off the FDA shortage list while generic ADHD med supply squeeze persists
In a welcome respite from the persistent nationwide Adderall shortage, Teva seems to have gotten a handle on its supply. The drugmaker has all of its Adderall products marked as available on the FDA’s shortage list, except for the 5-mg version of its generic offering, which is estimated to see supply recovery in June.
ADHD Treatment Linked to Higher Long-Term Risk for Stroke and Heart Failure
Adult patients receiving treatment for attention-deficit/hyperactivity disorder (ADHD) for the first time have an increased 10-year risk for stroke, heart failure, and a composite cardiovascular outcome, with a higher risk occurring with a higher dosage, according to a study in the Journal of the American College of Cardiology.
One in two children with ADHD experience emotional problems, study finds
Cambridge scientists have shown that problems regulating emotions—which can manifest as depression, anxiety and explosive outbursts—may be a core symptom of attention deficit hyperactivity disorder (ADHD). In research published in Nature Mental Health, the team found that as many as one in two children with ADHD show signs of emotional dysregulation, and that Ritalin—the commonly-prescribed drug to help the condition—appears to be less effective at treating this symptom.
Transitional Neonatal Hypoglycemia Tied to Adverse Neurodevelopmental Outcomes
Neonatal hypoglycemia is associated with an increased risk for suboptimal neurodevelopmental outcomes in mid-childhood, according to study findings published in JAMA Network Open.
‘A Unique Challenge’: What English Learners With Disabilities Need
Students with disabilities face a gamut of challenges when it comes to accessing high-quality K-12 education, including a shortage of specialized teachers. The nation’s growing English-learner population faces outsized needs as their English-language proficiency scores remain lower than pre-COVID-19-pandemic averages, and immigrant English learners in particular require more trauma-informed instruction.
Short Sleep Increases Obesity Risk Among Adolescents With Unmedicated ADHD
Adolescents with unmedicated attention-deficit/hyperactivity disorder (ADHD) who meet sleep guidelines have a lower risk for overweight and obesity (OW/OB) than those with short sleep duration, according to study findings published in the Journal of Pediatric Psychology.
FDA Clears Cingulate to File NDA for CTx-1301 in the Treatment of ADHD
Cingulate Inc has announced alignment with the US Food and Drug Administration (FDA) on the requirements for filing a New Drug Application (NDA) for its lead candidate, CTx-1301 (dexmethylphenidate). This medication is intended for the treatment of attention-deficit /hyperactivity disorder (ADHD) in patients aged 6 years and older.1
Scientists find link between ADHD and gaming disorder in college students
A study of university students in Lebanon found that 35.7% of those suffering from gaming disorder also suffer from attention-deficit/hyperactivity disorder (ADHD). This percentage was 24% among those without gaming disorder. Interestingly, the association between ADHD and gaming disorder was stronger in females than in males. The research was published in the journal PLOS ONE.
Understanding Primary and Associated Symptoms in Adult ADHD
Adults in the United States are seeking assessment, diagnosis, and treatment for attention-deficit/hyperactivity disorder (ADHD) at unprecedented rates. Psych Congress Network sat down with Lenard A. Adler, MD, director of the Adult ADHD Program at NYU Langone Health, on site at the 2024 APA Annual Meeting to dive deep into the particular ways that ADHD can manifest in adults through not just inattention, hyperactivity, and impulsivity, but also executive function deficits, emotional dysregulation, and sluggish cognitive tempo.